Authors: SCHWARZENBERGER P HARRISON L WEINACKER A MARROGI A BYRNE P RAMESH R THEODOSSIOU C GAUMER R SUMMER W FREEMAN SM KOLLS JK

Citation: P. Schwarzenberger et al., THE TREATMENT OF MALIGNANT MESOTHELIOMA WITH A GENE MODIFIED CANCER CELL-LINE - A PHASE-I STUDY, Human gene therapy, 9(17), 1998, pp. 2641-2649

Authors: NARAYAN A JI WZ ZHANG XY MARROGI A GRAFF JR BAYLIN SB EHRLICH M

Citation: A. Narayan et al., HYPOMETHYLATION OF PERICENTROMERIC DNA IN BREAST ADENOCARCINOMAS, International journal of cancer, 77(6), 1998, pp. 833-838

Authors: FREEMAN SM MCCUNE C ROBINSON W ABBOUD CN ABRAHAM GN ANGEL C MARROGI A

Citation: Sm. Freeman et al., THE TREATMENT OF OVARIAN-CANCER WITH A GENE MODIFIED CANCER VACCINE -A PHASE-I STUDY, Human gene therapy, 6(7), 1995, pp. 927-939

Authors: WHARTENBY KA ABRAHAM GN CALABRESI PA ABBOUD CN CALABRESI P MARROGI A FREEMAN SM

Citation: Ka. Whartenby et al., GENE-MODIFIED CELLS FOR THE TREATMENT OF CANCER, Pharmacology & therapeutics, 66(1), 1995, pp. 175-190

Authors: DEVITO J FUNG H MEROGI A BOH E COCKERELL C STEWART K FREEMAN S MARROGI A

Citation: J. Devito et al., BORRELIA-BURGDORFERI IS NOT A CONTRIBUTING FACTOR IN PATHOGENESIS OF MORPHEA SCLERODERMA LICHEN-SCLEROSUS-ET-ATROPHICUS - A POLYMERASE CHAIN-REACTION (PCR) STUDY OF 36 CASES, Journal of investigative dermatology, 104(4), 1995, pp. 654-654